2023 Second quarter announcement

We announced our second quarter 2023 results on Wednesday 26 July. Access our Q2 2023 results and latest Annual Report below.

We’re confident in our future

Our bold ambitions for patients are reflected in our commitments to a step-change in growth and performance over the period to 2026. This means more GSK vaccines and medicines, including innovative new products, will reach more people than ever before.

Speeches and presentations

HIV cell

Getting ahead of HIV with ViiV Healthcare management

Register for the webcast
28 September 2023

Join ViiV Healthcare management for a virtual event on 28 September at 9:00 AM EDT / 2:00 PM BST. The event, "Getting ahead of HIV," will feature a presentation, and an interactive Q&A. A replay will be available on demand.

Emma Walmsley

BofA 2023 Global Healthcare Conference

Listen to the webcast
14 September 2023

Emma Walmsley, Chief Executive Officer, participated in a fireside chat at the BofA Global Healthcare Conference on Thursday 14 September at 09:05 BST.

Citi’s 18th Annual BioPharma Conference

Listen to the webcast
07 September 2023

Phil Dormitzer, SVP, Head of Vaccines R&D joined Andrew Baum in a fireside chat at Citi’s 18th Annual BioPharma Conference which took place Thursday, September 7th at 8:50am ET/1:50pm UK.


Getting ahead of Infectious Disease with GSK management

Watch webcast recordings
27 June 2023

The virtual event featured a presentation, four breakout sessions and an interactive Q&A. Recordings of all sessions are available on demand.

GSK share price

Share price tool

Detailed information on GSK's share price, including an interactive chart

Go to share price tool
two scientists talking

Get in touch with our investor team